Neha Dangayach

Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial

Magdy Selim, Lydia D. Foster, Claudia S. Moy et al. · The Lancet Neurology · 2019 · 239 citations · Full text

Thrombosis, Reperfusion Injury, Deferoxamine Mesylate +11

An attention based deep learning model of clinical events in the intensive care unit

Deepak Kaji, John R. Zech, Jun Kim et al. · PLoS ONE · 2019 · 192 citations · Full text

Engineering, Machine Learning, Intensive Care Unit +15

Postintensive Care Syndrome in Survivors of Critical Illness Related to Coronavirus Disease 2019: Cohort Study From a New York City Critical Care Recovery Clinic*

Miguel Martillo, Neha Dangayach, Laura Tabacof et al. · Critical Care Medicine · 2021 · 160 citations

Oropharyngeal Cleansing With 0.2% Chlorhexidine for Prevention of Nosocomial Pneumonia in Critically Ill Patients

Tanmay S. Panchabhai, Neha Dangayach, Anand Krishnan et al. · CHEST Journal · 2009 · 130 citations

Critically Ill Patients, Antibiotics, Healthcare-associated Infection +8

COVID‐19 critical illness pathophysiology driven by diffuse pulmonary thrombi and pulmonary endothelial dysfunction responsive to thrombolysis

Hooman Poor, Corey E. Ventetuolo, Thomas M. Tolbert et al. · Clinical and Translational Medicine · 2020 · 123 citations · Full text